BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11292713)

  • 1. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.
    Novotny LA; Clements JD; Bakaletz LO
    Mucosal Immunol; 2011 Jul; 4(4):456-67. PubMed ID: 21326197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and immunogenicity evaluation of C-HapS-P6 fusion protein vaccine against nontypeable Haemophilus influenzae in mice.
    Hu N; Li W; Zhao Z; Chang Y; Wang C; Zhang Y
    Int J Med Microbiol; 2024 Mar; 314():151616. PubMed ID: 38461565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An infant mouse model of influenza-driven nontypeable
    Landwehr KR; Granland CM; Martinovich KM; Scott NM; Seppanen EJ; Berry L; Strickland D; Fulurija A; Richmond PC; Kirkham L-AS
    Infect Immun; 2024 May; 92(5):e0045323. PubMed ID: 38602405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients.
    Baffetta F; Buonsanti C; Moraschini L; Aprea S; Canè M; Lombardi S; Contorni M; Rondini S; Arora AK; Bardelli M; Finco O; Serruto D; Paccani SR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2343544. PubMed ID: 38655676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.
    Webb DC; Cripps AW
    Infect Immun; 1999 May; 67(5):2138-44. PubMed ID: 10225866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual orientation of the outer membrane lipoprotein P6 of nontypeable haemophilus influenzae.
    Michel LV; Snyder J; Schmidt R; Milillo J; Grimaldi K; Kalmeta B; Khan MN; Sharma S; Wright LK; Pichichero ME
    J Bacteriol; 2013 Jul; 195(14):3252-9. PubMed ID: 23687267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otitis media associated polymorphisms in the hemin receptor HemR of nontypeable Haemophilus influenzae.
    LaCross NC; Marrs CF; Gilsdorf JR
    Infect Genet Evol; 2014 Aug; 26():47-57. PubMed ID: 24820341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontypeable Haemophilus influenzae: pathogenesis and prevention.
    Foxwell AR; Kyd JM; Cripps AW
    Microbiol Mol Biol Rev; 1998 Jun; 62(2):294-308. PubMed ID: 9618443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.
    Kunthalert D; Novotny LA; Massa HM; Ulett GC; Bakaletz LO; Kyd JM; Cripps AW
    Hum Vaccin Immunother; 2013 Mar; 9(3):625-35. PubMed ID: 23292125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein.
    El-Adhami W; Kyd JM; Bastin DA; Cripps AW
    Infect Immun; 1999 Apr; 67(4):1935-42. PubMed ID: 10085039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae.
    Lugade AA; Vethanayagam RR; Nasirikenari M; Bogner PN; Segal BH; Thanavala Y
    Am J Respir Cell Mol Biol; 2011 Sep; 45(3):557-65. PubMed ID: 21216970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae.
    Murphy TF; Kirkham C; Lesse AJ
    Infect Immun; 2006 Sep; 74(9):5169-76. PubMed ID: 16926409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models for the study of mucosal vaccination against otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2008 Mar; 26(12):1501-24. PubMed ID: 18295938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A2ml1-Knockout mouse as an animal model for non-syndromic otitis media.
    Elling CL; Gomez HZ; Lee NK; Hirsch SD; Santos-Cortez RLP
    Int J Pediatr Otorhinolaryngol; 2024 Jun; 181():111980. PubMed ID: 38759260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway.
    Konduru AS; Lee BC; Li JD
    Sci Rep; 2016 Aug; 6():31695. PubMed ID: 27538525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of the hyaluronan receptor CD44 affects the course of bacterial otitis media and reduces leukocyte recruitment to the middle ear.
    Lim HW; Pak K; Kurabi A; Ryan AF
    BMC Immunol; 2019 Jun; 20(1):20. PubMed ID: 31226944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontypeable
    Gönüllü E; Özkan N; Soysal A; Acıoğlu E; Tavil EB; Ötgün SN; Karaböcüoğlu M
    Case Rep Infect Dis; 2021; 2021():8845200. PubMed ID: 34007496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Landscape of
    Allonce J; Ahsan M; Browne A; Witherell R; Rasnake M
    Case Rep Infect Dis; 2024; 2024():5571104. PubMed ID: 38694252
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a nontypeable Haemophilus influenzae thermonuclease.
    Cho C; Chande AT; Gakhar L; Hunt J; Ketterer MR; Apicella MA
    PLoS One; 2018; 13(5):e0197010. PubMed ID: 29746527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.